Close Menu

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

By signing up, you agree to the our terms and our Privacy Policy agreement.

What's Hot

Jamie Dimon says JP Morgan may rethink London office if Starmer ousted

May 13, 2026

European shares rise as oil prices slip on fragile US-Iran ceasefire

May 13, 2026

SoftBank posts $46 billion gain at Vision Fund driven by OpenAI bet

May 13, 2026

Facebook X (Twitter) Instagram

Addison Markets

Home
USA
Europe
Business
Investing
Tech
Politics
Contact Us

Addison Markets

Home»Investing»SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand

Investing

SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand

By franperez66q@protonmail.comMay 13, 2026No Comments1 Min Read

Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email

Facebook Twitter LinkedIn Pinterest Telegram Email

SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand

Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

franperez66q@protonmail.com

Website

European shares rise as oil prices slip on fragile US-Iran ceasefire

May 13, 2026

Siemens Q2 profit misses forecasts, orders surge

May 13, 2026

JPMorgan to reshuffle investment bank chiefs on wider overhaul, FT reports

May 13, 2026

Breeze Acquisition Corp. II prices $125 million IPO at $10 per unit

May 13, 2026

Nidec shares slump after co flags quality control misconduct

May 13, 2026

Samsung shares drop after labor union talks fall through

May 13, 2026

Top Reviews

Jamie Dimon says JP Morgan may rethink London office if Starmer ousted

May 13, 2026

European shares rise as oil prices slip on fragile US-Iran ceasefire

May 13, 2026

SoftBank posts $46 billion gain at Vision Fund driven by OpenAI bet

May 13, 2026

European markets: Stoxx 600, FTSE, DAX, Iran news, UK Starmer latest

May 13, 2026

Privacy Policy
Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.

Subscribe to Updates

What's Hot

SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand

Related Posts